Results 151 to 160 of about 17,734 (168)

PTD4-apoptin protein and dacarbazine show a synergistic antitumor effect on B16-F1 melanoma in vitro and in vivo [PDF]

open access: yesEuropean Journal of Pharmacology, 2011
PTD4-apoptin protein enters cells and harbors tumor-selective cell death activity. Dacarbazine is the mainstay of treatment for malignant melanoma. In this study, we investigated the cytotoxic effect of PTD4-apoptin protein and/or dacarbazine in mouse ...
Lei He, Mathieu H M Noteborn
exaly   +2 more sources

A randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanoma

open access: yesAnnals of Oncology, 2015
Background: The efficacy and safety of nab-paclitaxel versus dacarbazine in patients with metastatic melanoma was evaluated in a phase III randomized, controlled trial. Patients and methods: Chemotherapy-naïve patients with stage IV melanoma received nab-
Michele del Vecchio   +2 more
exaly   +2 more sources

Ex vivo model of human skin (hOSEC) for assessing the dermatokinetics of the anti-melanoma drug Dacarbazine

European Journal of Pharmaceutical Sciences, 2021
Fabiola Praca   +2 more
exaly  

Caffeine improves the cytotoxic effect of dacarbazine on B16F10 murine melanoma cells

Bioorganic Chemistry, 2022
Tiago Bervelieri Madeira   +2 more
exaly  

A randomised, phase II study of intetumumab, an anti-αv-integrin mAb, alone and with dacarbazine in stage IV melanoma

British Journal of Cancer, 2011
Dirk Schadendorf   +2 more
exaly  

Electrochemical Behaviour of the Anticancer Dacarbazine‐Cu2+ Complex and Its Analytical Applications

Electroanalysis, 2011
Hossieny Ibrahim   +2 more
exaly  

Home - About - Disclaimer - Privacy